ArticleBlood cancer journal2018

NS-018 reduces myeloma cell proliferation and suppresses osteolysis through inhibition of the JAK2 and Src signaling pathways.

Ayumi Honda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.